Hirohisa Kano

29 papers · 234 indexed citations

Immediate Impact

60 hit

Sub-graph 1 of 19

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach

2025 Hit

EGF receptor in organ development, tissue homeostasis and regeneration

2025 Hit

2 intermediate papers

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

2020

Abstract 2131: Significant combination benefit of anti-VEGFR antibody and oncogene-targeted agents in EGFR or ALK mutant NSCLC cells

2019

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hirohisa Kano	110	100	42	33	31	29	234
Saulius Paškauskas	91 0.8×	67 0.7×	41 1.0×	22 0.7×	16 0.5×	24	324
Ratna Paul	59 0.5×	50 0.5×	34 0.8×	10 0.3×	27 0.9×	26	330
T.-U. Hausamen	73 0.7×	112 1.1×	83 2.0×	25 0.8×	8 0.3×	30	306
Christian Franke	96 0.9×	37 0.4×	57 1.4×	11 0.3×	50 1.6×	21	290
Mohammad Hossein Jarahzadeh	26 0.2×	55 0.6×	26 0.6×	42 1.3×	33 1.1×	23	225
Jordan T. Lee	76 0.7×	234 2.3×	50 1.2×	11 0.3×	23 0.7×	22	308
Burcu Barutçuoğlu	20 0.2×	46 0.5×	83 2.0×	34 1.0×	22 0.7×	33	314
Özgür Haki Yüksel	82 0.7×	73 0.7×	29 0.7×	9 0.3×	12 0.4×	36	254
Antonino Carmelo Tralongo	52 0.5×	120 1.2×	66 1.6×	11 0.3×	11 0.4×	19	237
Jie Guan	55 0.5×	66 0.7×	63 1.5×	74 2.2×	18 0.6×	27	325

Loading papers...